Search

Khatol S. Shahnan Shah

Examiner (ID: 10988, Phone: (571)272-0863 , Office: P/1645 )

Most Active Art Unit
1645
Art Unit(s)
1645
Total Applications
690
Issued Applications
340
Pending Applications
103
Abandoned Applications
265

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 17793505 [patent_doc_number] => 20220252597 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-08-11 [patent_title] => New Core/Shell Materials of Nanowire/Graphene on Low-Cost RFID Tags for Rapidly Sensing Live Cell Metabolites at Single-Cell Sensitivity [patent_app_type] => utility [patent_app_number] => 17/670408 [patent_app_country] => US [patent_app_date] => 2022-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3454 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17670408 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/670408
New Core/Shell Materials of Nanowire/Graphene on Low-Cost RFID Tags for Rapidly Sensing Live Cell Metabolites at Single-Cell Sensitivity Feb 10, 2022 Abandoned
Array ( [id] => 19097791 [patent_doc_number] => 20240117019 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-04-11 [patent_title] => HUMAN MONOCLONAL ANTIBODIES AGAINST PNEUMOCOCCAL ANTIGENS [patent_app_type] => utility [patent_app_number] => 18/264733 [patent_app_country] => US [patent_app_date] => 2022-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35737 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18264733 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/264733
HUMAN MONOCLONAL ANTIBODIES AGAINST PNEUMOCOCCAL ANTIGENS Feb 6, 2022 Pending
Array ( [id] => 17609903 [patent_doc_number] => 20220152182 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-05-19 [patent_title] => VACCINE [patent_app_type] => utility [patent_app_number] => 17/588425 [patent_app_country] => US [patent_app_date] => 2022-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19993 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17588425 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/588425
VACCINE Jan 30, 2022 Pending
Array ( [id] => 17609858 [patent_doc_number] => 20220152137 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-05-19 [patent_title] => FEED SUPPLEMENT [patent_app_type] => utility [patent_app_number] => 17/588910 [patent_app_country] => US [patent_app_date] => 2022-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8144 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17588910 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/588910
Feed supplement Jan 30, 2022 Issued
Array ( [id] => 20262953 [patent_doc_number] => 12433921 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-10-07 [patent_title] => Bacteria [patent_app_type] => utility [patent_app_number] => 17/579006 [patent_app_country] => US [patent_app_date] => 2022-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8690 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 237 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17579006 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/579006
Bacteria Jan 18, 2022 Issued
Array ( [id] => 18483615 [patent_doc_number] => 20230210916 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-07-06 [patent_title] => Bacteriocin Production, Compositions and Methods of Use [patent_app_type] => utility [patent_app_number] => 17/573193 [patent_app_country] => US [patent_app_date] => 2022-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 40089 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17573193 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/573193
Bacteriocin Production, Compositions and Methods of Use Jan 10, 2022 Abandoned
Array ( [id] => 17564423 [patent_doc_number] => 20220128572 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-04-28 [patent_title] => IMMUNOLOGICAL SIGNATURES AND PARAMETERS PREDICTING THERAPEUTIC RESPONSES TO ANTI-TNF THERAPY [patent_app_type] => utility [patent_app_number] => 17/567623 [patent_app_country] => US [patent_app_date] => 2022-01-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6906 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17567623 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/567623
IMMUNOLOGICAL SIGNATURES AND PARAMETERS PREDICTING THERAPEUTIC RESPONSES TO ANTI-TNF THERAPY Jan 2, 2022 Abandoned
Array ( [id] => 17685865 [patent_doc_number] => 20220193157 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-23 [patent_title] => LACTOBACILLUS COMPOSITIONS AND METHODS FOR PREVENTION AND TREATMENT OF MICROBIAL INFECTION [patent_app_type] => utility [patent_app_number] => 17/557939 [patent_app_country] => US [patent_app_date] => 2021-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16533 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17557939 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/557939
None Dec 20, 2021 Issued
Array ( [id] => 17657463 [patent_doc_number] => 20220177928 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-09 [patent_title] => PRODUCTION OF SQUALENE FROM HYPER-PRODUCING YEASTS [patent_app_type] => utility [patent_app_number] => 17/555867 [patent_app_country] => US [patent_app_date] => 2021-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4383 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17555867 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/555867
PRODUCTION OF SQUALENE FROM HYPER-PRODUCING YEASTS Dec 19, 2021 Abandoned
Array ( [id] => 18449512 [patent_doc_number] => 20230190788 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-22 [patent_title] => Method and process to make chitosan-doped strontium oxide nanocomposite for bactericidal applications [patent_app_type] => utility [patent_app_number] => 17/551882 [patent_app_country] => US [patent_app_date] => 2021-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3064 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 1 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17551882 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/551882
Method and process to make chitosan-doped strontium oxide nanocomposite for bactericidal applications Dec 14, 2021 Issued
Array ( [id] => 17762672 [patent_doc_number] => 20220236284 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-07-28 [patent_title] => Therapeutically Triggering an Innate Immune Response in a Target Tissue [patent_app_type] => utility [patent_app_number] => 17/542820 [patent_app_country] => US [patent_app_date] => 2021-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 43282 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17542820 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/542820
Therapeutically Triggering an Innate Immune Response in a Target Tissue Dec 5, 2021 Pending
Array ( [id] => 17627257 [patent_doc_number] => 20220162272 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-05-26 [patent_title] => COMPOSITIONS AND METHODS OF DETERMINING A LEVEL OF INFECTION IN A SUBJECT [patent_app_type] => utility [patent_app_number] => 17/541365 [patent_app_country] => US [patent_app_date] => 2021-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14755 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 128 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17541365 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/541365
COMPOSITIONS AND METHODS OF DETERMINING A LEVEL OF INFECTION IN A SUBJECT Dec 2, 2021 Abandoned
Array ( [id] => 17685922 [patent_doc_number] => 20220193214 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-23 [patent_title] => Triple Vaccine for Diseases Caused by Salmonella typhimurium, Riemerella anatipestifer and Escherichia coli [patent_app_type] => utility [patent_app_number] => 17/532217 [patent_app_country] => US [patent_app_date] => 2021-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4371 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -2 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17532217 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/532217
Triple vaccine for diseases caused by Nov 21, 2021 Issued
Array ( [id] => 17561752 [patent_doc_number] => 20220125901 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-04-28 [patent_title] => TREATMENT OF CANCER USING RECALL ANTIGENS DELIVERED BY ATTENUATED BACTERIA [patent_app_type] => utility [patent_app_number] => 17/527488 [patent_app_country] => US [patent_app_date] => 2021-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5542 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17527488 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/527488
TREATMENT OF CANCER USING RECALL ANTIGENS DELIVERED BY ATTENUATED BACTERIA Nov 15, 2021 Abandoned
Array ( [id] => 20403062 [patent_doc_number] => 12493035 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-12-09 [patent_title] => Cellular vamp cleavage assay [patent_app_type] => utility [patent_app_number] => 17/451900 [patent_app_country] => US [patent_app_date] => 2021-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 24 [patent_no_of_words] => 13256 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17451900 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/451900
Cellular vamp cleavage assay Oct 21, 2021 Issued
Array ( [id] => 17482150 [patent_doc_number] => 20220089654 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-03-24 [patent_title] => MUTANT TRANSPORTERS FOR BACTERIAL UPTAKE OF TEREPHTHALIC ACID [patent_app_type] => utility [patent_app_number] => 17/472936 [patent_app_country] => US [patent_app_date] => 2021-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18333 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17472936 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/472936
Mutant transporters for bacterial uptake of terephthalic acid Sep 12, 2021 Issued
Array ( [id] => 18860304 [patent_doc_number] => 20230414738 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-12-28 [patent_title] => HAEMOPHILUS INFLUENZAE VACCINE AND METHODS OF USE [patent_app_type] => utility [patent_app_number] => 18/043241 [patent_app_country] => US [patent_app_date] => 2021-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16489 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -24 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18043241 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/043241
HAEMOPHILUS INFLUENZAE VACCINE AND METHODS OF USE Sep 9, 2021 Pending
Array ( [id] => 17155026 [patent_doc_number] => 20210316077 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-10-14 [patent_title] => BOTULINUM TOXIN PREFILLED CONTAINER [patent_app_type] => utility [patent_app_number] => 17/356300 [patent_app_country] => US [patent_app_date] => 2021-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11727 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17356300 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/356300
Botulinum toxin prefilled container Jun 22, 2021 Issued
Array ( [id] => 18737998 [patent_doc_number] => 20230346902 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-11-02 [patent_title] => Shigella-Tetravalent (Shigella4V) Bioconjugate [patent_app_type] => utility [patent_app_number] => 18/001551 [patent_app_country] => US [patent_app_date] => 2021-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30309 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18001551 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/001551
Shigella-Tetravalent (Shigella4V) Bioconjugate Jun 16, 2021 Pending
Array ( [id] => 17343521 [patent_doc_number] => 20220009852 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-01-13 [patent_title] => BACILLUS SUBTILIS BS40-4 STRAIN AND METHOD FOR COMPOSTING ORGANIC WASTES BY USING THE SAME [patent_app_type] => utility [patent_app_number] => 17/349960 [patent_app_country] => US [patent_app_date] => 2021-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3919 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17349960 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/349960
BACILLUS SUBTILIS BS40-4 STRAIN AND METHOD FOR COMPOSTING ORGANIC WASTES BY USING THE SAME Jun 16, 2021 Abandoned
Menu